The boron-oxygen core of borinate esters is responsible for the store-operated calcium entry potentiation ability

BMC Pharmacology

Volumn 11, Issue , 2011, Pages

  Dellis, Olivier ^a   Mercier, Pierre ^a   Chomienne, Christine ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; BENZENEBORONIC ACID; CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CARBON; DIMETHYLBENZ[A]ANTHRACENE; MESSENGER RNA; PHOSPHORUS; THAPSIGARGIN; 2-AMINOETHYL DIPHENYLBORINATE; ADENOSINE TRIPHOSPHATASE (CALCIUM); BORON DERIVATIVE; CALCIUM; CALCIUM CHANNEL; ENZYME INHIBITOR; ORAI1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; MODULATION; NONHUMAN; PROTEIN EXPRESSION; STORE OPERATED CALCIUM ENTRY; SURFACE PROPERTY; CELL LINE; CELL STRAIN U937; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BORON COMPOUNDS; CALCIUM; CALCIUM CHANNELS; CALCIUM-TRANSPORTING ATPASES; CELL LINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; JURKAT CELLS; MOLECULAR STRUCTURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THAPSIGARGIN; U937 CELLS;

EID: 78951488202     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-11-1     Document Type: Article

References (48)

1. Berridge MJ. Inositol trisphosphate and calcium signaling. Ann N Y Acad Sci 1995, 766:31-43. 10.1111/j.1749-6632.1995.tb26646.x, 7486679.
2. Feske S, Okamura H, Hogan PG, Rao A. Ca2+/calcineurin signalling in cells of the immune system. Biochem Biophys Res Commun 2003, 311:1117-1132. 10.1016/j.bbrc.2003.09.174, 14623298.
3. Chung SC, McDonald TV, Gardner P. Inhibition by SK&F 96365 of Ca2+ current, IL-2 production and activation in T lymphocytes. Br J Pharmacol 1994, 113:861-868. 1510420, 7858878.
4. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441:179-185. 10.1038/nature04702, 16582901.
5. Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, Koblan-Huberson M, Lis A, Fleig A, Penner R, Kinet JP. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol 2006, 8:771-773. 10.1038/ncb1435, 16733527.
6. Lewis RS. The molecular choreography of a store-operated calcium channel. Nature 2007, 446:284-287. 10.1038/nature05637, 17361175.
7. Mercer JC, Dehaven WI, Smyth JT, Wedel B, Boyles RR, Bird GS, Putney JW. Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. J Biol Chem 2006, 281:24979-24990. 10.1074/jbc.M604589200, 1633822, 16807233.
8. Gwack Y, Srikanth S, Feske S, Cruz-Guilloty F, Oh-hora M, Neems DS, Hogan PG, Rao A. Biochemical and functional characterization of Orai proteins. J Biol Chem 2007, 282:16232-16243. 10.1074/jbc.M609630200, 17293345.
9. Derler I, Fritsch R, Schindl R, Romanin C. CRAC inhibitors: identification and potential. Expert Opinion Drug Discovery 2008, 3:787-800.
10. Huang YH, Hoebe K, Sauer K. New therapeutic targets in immune disorders: ItpkB, Orai1 and UNC93B. Expert Opin Ther Targets 2008, 12:391-413. 10.1517/14728222.12.4.391, 18348677.
11. Sweeney ZK, Minatti A, Button DC, Patrick S. Small-Molecule Inhibitors of Store-Operated Calcium Entry. ChemMedChem 2009,
12. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. J Biochem 1997, 122:498-505.
13. Bilmen JG, Wootton LL, Godfrey RE, Smart OS, Michelangeli F. Inhibition of SERCA Ca2+ pumps by 2-aminoethoxydiphenyl borate (2-APB). 2-APB reduces both Ca2+ binding and phosphoryl transfer from ATP, by interfering with the pathway leading to the Ca2+-binding sites. Eur J Biochem 2002, 269:3678-3687. 10.1046/j.1432-1033.2002.03060.x, 12153564.
14. Missiaen L, Callewaert G, De Smedt H, Parys JB. 2-Aminoethoxydiphenyl borate affects the inositol 1,4,5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores in permeabilized A7r5 cells. Cell Calcium 2001, 29:111-116. 10.1054/ceca.2000.0163, 11162848.
15. Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD, Berridge MJ, Seo JT, Roderick HL. 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 2003, 34:97-108. 10.1016/S0143-4160(03)00026-5, 12767897.
16. Kukkonen JP, Lund PE, Akerman KE. 2-aminoethoxydiphenyl borate reveals heterogeneity in receptor-activated Ca(2+) discharge and store-operated Ca(2+) influx. Cell Calcium 2001, 30:117-129. 10.1054/ceca.2001.0219, 11440469.
17. Prakriya M, Lewis RS. Potentiation and inhibition of Ca(2+) release-activated Ca(2+) channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP(3) receptors. J Physiol 2001, 536:3-19. 10.1111/j.1469-7793.2001.t01-1-00003.x, 2278849, 11579153.
18. Ma HT, Venkatachalam K, Parys JB, Gill DL. Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes. J Biol Chem 2002, 277:6915-6922. 10.1074/jbc.M107755200, 11741932.
19. Chung MK, Lee H, Mizuno A, Suzuki M, Caterina MJ. 2-aminoethoxydiphenyl borate activates and sensitizes the heat-gated ion channel TRPV3. J Neurosci 2004, 24:5177-5182. 10.1523/JNEUROSCI.0934-04.2004, 15175387.
20. Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, Lee LY, Wood JD, Zhu MX. 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J Biol Chem 2004, 279:35741-35748. 10.1074/jbc.M404164200, 15194687.
21. Lievremont JP, Bird GS, Putney JW. Mechanism of inhibition of TRPC cation channels by 2-aminoethoxydiphenylborane. Mol Pharmacol 2005, 68:758-762.
22. Dobrydneva Y, Abelt CJ, Dovel B, Thadigiri CM, Williams RL, Blackmore PF. 2-aminoethoxydiphenyl borate as a prototype drug for a group of structurally related calcium channel blockers in human platelets. Mol Pharmacol 2006, 69:247-256.
23. Dobrydneva Y, Blackmore P. 2-Aminoethoxydiphenyl borate directly inhibits store-operated calcium entry channels in human platelets. Mol Pharmacol 2001, 60:541-552.
24. Zhou H, Iwasaki H, Nakamura T, Nakamura K, Maruyama T, Hamano S, Ozaki S, Mizutani A, Mikoshiba K. 2-Aminoethyl diphenylborinate analogues: selective inhibition for store-operated Ca2+ entry. Biochem Biophys Res Commun 2007, 352:277-282. 10.1016/j.bbrc.2006.10.174, 17140548.
25. Suzuki AZ, Ozaki S, Goto JI, Mikoshiba K. Synthesis of bisboron compounds and their strong inhibitory activity on store-operated calcium entry. Bioorg Med Chem Lett 2010, 20:1395-1398. 10.1016/j.bmcl.2009.12.108, 20097561.
26. Dellis O, Gangloff SC, Paulais M, Tondelier D, Rona JP, Brouillard F, Bouteau F, Guenounou M, Teulon J. Inhibition of the calcium release-activated calcium (CRAC) current in Jurkat T cells by the HIV-1 envelope protein gp160. J Biol Chem 2002, 277:6044-6050. 10.1074/jbc.M111831200, 11744714.
27. Bird GS, Dehaven WI, Smyth JT, Putney JW. Methods for studying store-operated calcium entry. Methods 2008, 46:204-212. 10.1016/j.ymeth.2008.09.009, 2643845, 18929662.
28. Lis A, Peinelt C, Beck A, Parvez S, Monteilh-Zoller M, Fleig A, Penner R. CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr Biol 2007, 17:794-800. 10.1016/j.cub.2007.03.065, 17442569.
29. Sugawara H, Kurosaki M, Takata M, Kurosaki T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J 1997, 16:3078-3088. 10.1093/emboj/16.11.3078, 1169926, 9214625.
30. McCormack T, Baumeister W, Grenier L, Moomaw C, Plamondon L, Pramanik B, Slaughter C, Soucy F, Stein R, Zuhl F, Dick L. Active site-directed inhibitors of Rhodococcus 20 S proteasome. Kinetics and mechanism. J Biol Chem 1997, 272:26103-26109. 10.1074/jbc.272.42.26103, 9334174.
31. Chung MK, Guler AD, Caterina MJ. Biphasic currents evoked by chemical or thermal activation of the heat-gated ion channel, TRPV3. J Biol Chem 2005, 280:15928-15941. 10.1074/jbc.M500596200, 15722340.
32. Juvin V, Penna A, Chemin J, Lin YL, Rassendren FA. Pharmacological characterization and molecular determinants of the activation of transient receptor potential V2 channel orthologs by 2-aminoethoxydiphenyl borate. Mol Pharmacol 2007, 72:1258-1268. 10.1124/mol.107.037044, 17673572.
33. Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2001, 2:316-324. 10.1038/86318, 11276202.
34. Motiani RK, Abdullaev IF, Trebak M. A novel native store-operated calcium channel encoded by Orai3:Selective requirement of Orai3 versus Orai1 in estrogen receptor positive versus estrogen receptor negative breast cancer cells. J Biol Chem 2010,
35. Ambudkar IS, Ong HL, Liu X, Bandyopadhyay BC, Cheng KT. TRPC1: the link between functionally distinct store-operated calcium channels. Cell Calcium 2007, 42:213-223. 10.1016/j.ceca.2007.01.013, 17350680.
36. Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L. Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA 2007, 104:4682-4687. 10.1073/pnas.0611692104, 1838661, 17360584.
37. Varga-Szabo D, Authi KS, Braun A, Bender M, Ambily A, Hassock SR, Gudermann T, Dietrich A, Nieswandt B. Store-operated Ca(2+) entry in platelets occurs independently of transient receptor potential (TRP) C1. Pflugers Arch 2008, 457:377-387. 10.1007/s00424-008-0531-4, 18546016.
38. Soboloff J, Spassova MA, Tang XD, Hewavitharana T, Xu W, Gill DL. Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem 2006, 281:20661-20665. 10.1074/jbc.C600126200, 16766533.
39. Scrimgeour N, Litjens T, Ma L, Barritt GJ, Rychkov GY. Properties of Orai1 mediated store-operated current depend on the expression levels of STIM1 and Orai1 proteins. J Physiol 2009, 2718249, 19403622.
40. Richardson PG, Hideshima T, Anderson KC. Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers. Cancer Control 2003, 10:361-369.
41. Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 2001, 8:739-758. 10.1016/S1074-5521(01)00056-4, 11514224.
42. Adams J, Behnke M, Chen S, Cruickshank AA, Dick LR, Grenier L, Klunder JM, Ma YT, Plamondon L, Stein RL. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg Med Chem Lett 1998, 8:333-338. 10.1016/S0960-894X(98)00029-8, 9871680.
43. Walker B, Lynas JF. Strategies for the inhibition of serine proteases. Cell Mol Life Sci 2001, 58:596-624. 10.1007/PL00000884, 11361094.
44. Spassova MA, Soboloff J, He LP, Xu W, Dziadek MA, Gill DL. STIM1 has a plasma membrane role in the activation of store-operated Ca(2+) channels. Proc Natl Acad Sci USA 2006, 103:4040-4045. 10.1073/pnas.0510050103, 1449642, 16537481.
45. Peinelt C, Lis A, Beck A, Fleig A, Penner R. 2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1-dependent gating of CRAC channels. J Physiol 2008, 586:3061-3073. 10.1113/jphysiol.2008.151365, 2538778, 18403424.
46. Dellis O, Arbabian A, Brouland JP, Kovacs T, Rowe M, Chomienne C, Joab I, Papp B. Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus Latent Membrane Protein-1. Mol Cancer 2009, 8:59. 10.1186/1476-4598-8-59, 19650915.
47. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
48. Nasmith PE, Grinstein S. Phorbol ester-induced changes in cytoplasmic Ca2+ in human neutrophils. Involvement of a pertussis toxin-sensitive G protein. J Biol Chem 1987, 262:13558-13566.